EPS, expectations were $0.03. Operator: Good morning, and welcome to Bausch + Lomb’s First Quarter 2025 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note ...

Xiidra. Zaltrap. Gilotrif. Taltz. What those words have in common, other than sounding like minor “Star Wars” characters, is ...

Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...

Vision Care revenue increased by 5%, driven by Daily SiHy lenses (up 42%) and Blink products (up 85%). The Surgical segment grew by 11%, led by premium IOLs (up 77%), while Pharmaceuticals posted 1% ...